Potential Side Effects of Mistletoe Injections in Cancer Care

 Mistletoe injections, commonly used as part of complementary cancer therapy, are derived from the Viscum album plant. Widely administered in Europe and increasingly gaining interest in countries like India, these injections aim to boost the immune system, improve quality of life, and support the body during chemotherapy or radiation. ABNOBA GmbH, a German-based research pharmaceutical company, is among the leading producers of standardized mistletoe extracts, ensuring quality and safety.

While generally considered safe and well-tolerated, mistletoe injections may cause certain side effects. The most frequent include localized skin reactions such as redness, swelling, and mild itching at the injection site. These are usually harmless and fade within a day or two. They are also seen as a sign that the immune system is responding.

Mild flu-like symptoms—such as low-grade fever, fatigue, or chills—can occur shortly after administration, especially in the early stages of treatment. These typically decrease over time as the body adjusts to the therapy.

In rare instances, more serious side effects can develop, including allergic reactions, dizziness, or increased temperature beyond 38.5°C. Though uncommon, these symptoms should be monitored by a healthcare provider.

Patients with autoimmune diseases or who are pregnant should consult their doctor before starting mistletoe therapy.

ABNOBA India emphasizes the importance of professional supervision to ensure safe, tailored use of mistletoe injections. With expert guidance, side effects can be managed effectively, allowing patients to benefit from this supportive treatment option.